Holen Sie sich die Stockscreener-App
5.58
6.08%
0.32
Handel nachbörslich:
5.57
-0.010
-0.18%
Schlusskurs vom Vortag:
$5.26
Offen:
$5.17
24-Stunden-Volumen:
831.43K
Relative Volume:
0.80
Marktkapitalisierung:
$822.89M
Einnahmen:
$170.28M
Nettoeinkommen (Verlust:
$-225.25M
KGV:
-4.1955
EPS:
-1.33
Netto-Cashflow:
$-167.02M
1W Leistung:
+18.47%
1M Leistung:
+1.09%
6M Leistung:
+85.38%
1J Leistung:
+12.27%
1-Tages-Spanne:
$5.09
$5.59
1-Wochen-Bereich:
$4.65
$5.59
52-Wochen-Spanne:
$2.28
$5.795
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Firmenname
Adaptive Biotechnologies Corp
Sektor
Branche
Telefon
206-659-0067
Adresse
1165 EASTLAKE AVE E, SEATTLE, WA
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-21 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Neutral |
| 2022-02-16 | Bestätigt | BTIG Research | Buy |
| 2022-02-16 | Bestätigt | BofA Securities | Buy |
| 2022-02-16 | Bestätigt | Goldman | Neutral |
| 2022-02-16 | Bestätigt | JP Morgan | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-03-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Eingeleitet | Goldman | Buy |
| 2019-07-23 | Eingeleitet | BTIG Research | Buy |
| 2019-07-22 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-22 | Eingeleitet | Cowen | Outperform |
| 2019-07-22 | Eingeleitet | Goldman | Neutral |
| 2019-07-22 | Eingeleitet | Guggenheim | Buy |
| 2019-07-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Sumitomo Mitsui Trust Group's Strategic Acquisition in Adaptive Biotechnologies - GuruFocus.com
Vanguard Group Inc's Strategic Acquisition in Adaptive Biotechno - GuruFocus.com
November 2024's Top US Penny Stocks With Growth Potential - Yahoo Finance
ADPT (Adaptive Biotechnologies) Cyclically Adjusted Book pe - GuruFocus.com
Adaptive Biotechnologies (ADPT) Scheduled to Post Earnings on Thursday - MarketBeat
Cancer Immunotherapy Global Market 2024 To Reach $175.39Billion By 2028 At Rate Of 12.1% - EIN News
Cancer Immunotherapy Global Market 2024 To Reach $175.39 Billion By 2028 At Rate Of 12.1% - EIN News
ADPT (Adaptive Biotechnologies) PE Ratio : At Loss (As of Oct. 30, 2024) - GuruFocus.com
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Receives $7.00 Consensus Price Target from Analysts - MarketBeat
Perhaps timely catching Adaptive Biotechnologies Corp (ADPT) would be a good idea - SETE News
Adaptive Biotechnologies Corp [ADPT] Stock sold by Insider Taylor Stacy L for $0.12 million - Knox Daily
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap UpStill a Buy? - MarketBeat
Stock Surge: Adaptive Biotechnologies Corp (ADPT) Closes at 4.94, Marking a 0.61 Increase/Decrease - The Dwinnex
Should investors be concerned about Adaptive Biotechnologies Corp (ADPT)? - US Post News
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap DownTime to Sell? - MarketBeat
Insider Selling: Taylor Stacy L, Adaptive Biotechnologies Corp [ADPT] SVP and General Counsel divested 26,922 shares – Knox Daily - Knox Daily
ADPT’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 4.8%Here's Why - MarketBeat
Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024 - Yahoo Finance
Adaptive Biotechnologies (STU:1HM) Momentum Rank : 8 (As of Oct. 09, 2024) - GuruFocus.com
Adaptive Biotechnologies (STU:1HM) Growth Rank : 9 (As of Oct. 09, 2024) - GuruFocus.com
A better buy-in window may exist right now for Adaptive Biotechnologies Corp (ADPT) - SETE News
Adaptive Biotechnologies Corp’s Market Journey: Closing Weak at 5.25, Down -2.96 - The Dwinnex
Have you been able to find a good deal on Adaptive Biotechnologies Corp’s shares? - US Post News
Examining the Potential Price Growth of Adaptive Biotechnologies Corp (ADPT) - Knox Daily
Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 12-Month HighShould You Buy? - MarketBeat
ADPT stock touches 52-week high at $5.54 amid market optimism - Investing.com
Adaptive Biotechnologies Corp [ADPT] Shares Fall Approximately -0.96% Over the Year - Knox Daily
Millennium Management LLC Has $33.53 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $8.00 at BTIG Research - MarketBeat
Adaptive Biotechnologies Corp (ADPT) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
The Potential Rise in the Price of CIENA Corp. (CIEN) following insiders activity - Knox Daily
Investing in Adaptive Biotechnologies Corp (ADPT) might be a great opportunity, but the stock is a bit overvalued - US Post News
Adaptive Biotechnologies Corp (ADPT) may enjoy gains as insiders got busy in the recent days - Knox Daily
Adaptive Biotechnologies Shares Rise After EU Certification for Lymphoid Test clonoSEQ - MarketWatch
Check Out Adaptive Biotechnologies Corp (ADPT)’s Trade Data Rather Than the Analysts’ Views - SETE News
Crude Oil Down Over 2%; US Initial Jobless Claims Fall - Benzinga
Was there any good news for Adaptive Biotechnologies Corp (ADPT) stock in the last session? - US Post News
Adaptive Biotechnologies Corp (ADPT) gets rating Resumed from JP Morgan - Knox Daily
Federated Hermes Inc. Sells 1,244,445 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Federated Hermes Inc. Has $207,000 Stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - MarketBeat
Daily Progress: Adaptive Biotechnologies Corp (ADPT) Drop -8.39, Closing at 4.26 - The Dwinnex
The ADPT Stock Puzzle: Unraveling Adaptive Biotechnologies Corp’s Fluctuating Performance - The InvestChronicle
ADPT (Adaptive Biotechnologies) Current Ratio : 3.99 (As of Jun. 2024) - GuruFocus.com
Analysts Set Adaptive Biotechnologies Co. (NASDAQ:ADPT) Target Price at $6.40 - MarketBeat
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Acquired by Massachusetts Financial Services Co. MA - Defense World
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Down 5.2% - MarketBeat
This trade activity should not be overlooked: Adaptive Biotechnologies Corp (ADPT) - SETE News
Principal Financial Group Inc. Cuts Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
How did Adaptive Biotechnologies Corp (ADPT) fare last session? - US Post News
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):